Data-driven Healthcare Transformations
First of its kind, all-inclusive cardio-pulmonary platform for seamless and high-quality remote care across healthcare’s care continuum
US FDA 510(k) Cleared
CE Approved Medical Device
US Patented
Australia's Therapeutic Goods Administration (TGA) Approved
HIPAA & US FDA Cybersecurity Certified
ISO 13485 QMS Certified
Why Respiree?
Days in Advance Deterioration Detection with >90% Accuracy
End-to-End Secured EHR Dashboards
Decentralized Clinical Trials Platform with Digital Biomarker Development
Solutions Trusted by Partners and Patients:
Respiree Care
End-to-end enterprise-connected remote-care solution across healthcare’s care continuum, from hospital-at-home, to chronic disease management to rehabilitation
- Comprehensive lung-cardio biomarkers and insights
- Cellular hubs for ease in remote-data acquisitions
- Seamless software with enterprise and EHR system integrations
- Customizable feedback and alert systems to reduce readmissions and costs
Respiree OneBio
Integrating more than 1000s of pulmonary-cardio multi-modal biomarkers on a decentralized clinical trials platform with clinically validated software
- Cost-effective drug trials and developments
- Novel and comprehensive lung-cardio biomarker insights
- Improved drug therapeutics
- Accelerating better patient outcomes
Trusted by leading healthcare systems, medical technology companies, biopharma and patients
Awards
President's Technology Award 2024
ATS 2022 RIS Featured Start-up
Falling Walls Finalist 2022
Top 50 Southeast Asia Health Tech Startup in 2022
HealthTech 250 - Most promising Early-stage Ventures in 2022 Digital Health
